|
|
|
Volumn 2, Issue 2 SUPPL., 2004, Pages 36-39
|
|
Improving the management of chemotherapy-induced neutropenia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CARBOPLATIN;
COLONY STIMULATING FACTOR;
CYCLOPHOSPHAMIDE;
CYTOTOXIC AGENT;
DACARBAZINE;
DOXORUBICIN;
FLUOROURACIL;
METHOTREXATE;
NAVELBINE;
PREDNISONE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
VINBLASTINE;
VINCRISTINE SULFATE;
BONE MARROW SUPPRESSION;
BONE MARROW TOXICITY;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DRUG BLOOD LEVEL;
DRUG COST;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
EDITORIAL;
FEBRILE NEUTROPENIA;
GRAFT VERSUS HOST REACTION;
HEALTH CARE COST;
HEALTH ECONOMICS;
HODGKIN DISEASE;
HUMAN;
INFECTION;
LUNG CANCER;
LUNG NON SMALL CELL CANCER;
LYMPHOMA;
META ANALYSIS;
NEUTROPENIA;
NONHODGKIN LYMPHOMA;
OVARY CANCER;
QUALITY OF LIFE;
THORAX CANCER;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
CYTOKINES;
FILGRASTIM;
HUMANS;
MEDICAL ONCOLOGY;
NEOPLASMS;
NEUTROPENIA;
|
|
EID: 7244236603
PISSN: 15446794
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (3)
|
|
References (0)
|
